Levodopa Infusion Better Than Pills at Reducing Parkinson’s Symptoms

Translate to Spanish or other 102 languages!

Parkinson’s disease affects over 8.5 millionTrusted Source individuals worldwide, and prevalence has doubled in the past 25 years.. Image for illustration purposes
Parkinson’s disease affects over 8.5 millionTrusted Source individuals worldwide, and prevalence has doubled in the past 25 years.. Image for illustration purposes
- Advertisement -
  • Parkinson’s disease is the fastest growing neurological condition in the world, and the reasons for this are unclear. 
  • One of the main drugs offered to people with Parkinson’s disease is levodopa, which helps with symptoms affecting movement. 
  • A global team of researchers have now shown that the efficacy of the drug can be improved by being administered continuously via a pump, rather than orally, which is how it is usually taken. 

Parkinson’s disease affects over 8.5 millionTrusted Source individuals worldwide, and prevalence has doubled in the past 25 years.

Follow the link below to read the full story on Medical News Today: 

https://www.medicalnewstoday.com/articles/levodopa-infusion-better-than-pills-at-reducing-parkinsons-symptoms

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

Why Science Says to Ditch Hydrogen Peroxide for Wounds

Growing up, you may have heard that you should treat open wounds with hydrogen peroxide, but that’s no longer the case.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- Advertisement -